A Systematic Review and Meta-analysis of Antibiotic Resistance of Foodborne Pathogenic Bacteria in West Africa Between 2010 and 2020. 2023

N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
Centre National de la Recherche Scientifique et Technologique (CNRST)/ IRSAT / Département Technologie Alimentaire (DTA) / Bobo-Dioulasso, 03 BP 2393 Bobo-Dioulasso 03, Burkina Faso; Laboratoire de Biochimie et d'Immunologie Appliquée (LABIA). UFR en Sciences de la vie et de la terre. Ecole Doctorale Sciences et Technologies. Université Joseph Ki-Zerbo, 03 BP 7021 Ouagadougou 03, Burkina Faso. Electronic address: namwin.somda@gmail.com.

In the past, studies on antimicrobial resistance were carried out on pathogens in the clinical areas. However, since then, this phenomenon has become a general case both in the environment and in the food sector. This systematic review aimed to review the various scientific publications on the resistance of bacteria to antibiotics in foods in West Africa. An extensive literature search was carried out through an electronic database including PubMed, Google Scholar, Research Gate, and African Journals Online (AJOL). Articles published from fifteen countries of the Economic Community of West African States (ECOWAS) between 2010 and 2020 on antibiotic resistance of foodborne pathogens were included in the study. The titles and abstracts of the retrieved articles and then the full texts of the selected articles were reviewed. Out of the 565 articles found in our initial research, 149 publications (26.55%) were considered suitable for inclusion in this review. Globally, 2018, 2019, and 2020 had more included papers (n = 21 to 25) than the other years. Of the 149 publications analyzed, four types of food commodities were identified as products of high consumption based on the number of publications in the field such as poultry (39/149), read-to-eat food (22/149), meat, and animal products (20/149). Most studies have shown that E. coli has the highest prevalence followed by Salmonella and Staphylococcus. Only 33 (22.14%) of the 149 publications were based on further molecular characterization of the isolates. Publications analyzed showed that the most prevalent detected genes were tet(A), tet(B), tet(C), tet(K) blaTEM, catA1, catA2, cmlA, blaCTXM and qnrA, qnrB, qnrS, parC, and qepA4. From these results, antibiotic use in the food areas must be strongly regulated, especially in developing countries, particularly in Africa. This highlights the need to implement suitable and appropriate control strategies to reduce complications and prevent the dissemination of resistant bacteria isolates in foods. One health antimicrobial resistance surveillance system in the region must be a great concern.

UI MeSH Term Description Entries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000354 Africa, Western The geographical area of Africa comprising BENIN; BURKINA FASO; CABO VERDE, COTE D'IVOIRE (formerly Ivory Coast); GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO. Africa, West,West Africa,Western Africa
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
November 2017, International journal of antimicrobial agents,
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
January 2021, Frontiers in cellular and infection microbiology,
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
October 2020, Microbial drug resistance (Larchmont, N.Y.),
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
June 2018, Microbial drug resistance (Larchmont, N.Y.),
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
January 2022, Pathogens (Basel, Switzerland),
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
January 2023, The Pan African medical journal,
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
January 2024, Healthcare (Basel, Switzerland),
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
March 2022, Scientific reports,
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
April 2021, Iranian journal of basic medical sciences,
N S Somda, and A Tankoano, and A Métuor-Dabiré, and D Kaboré, and J O I Bonkoungou, and D S Kpoda, and B Sambe-Ba, and Y Dabiré, and C K S Saba, and I L Ouoba, and H Sawadogo-Lingani, and A Savadogo
October 2022, The Onderstepoort journal of veterinary research,
Copied contents to your clipboard!